左甲状腺素治疗不充分与平均血压及血压变异性升高相关
本研究利用2203例接受左甲状腺素(LT4)治疗的成人患者纵向数据,分析LT4治疗时间高于范围(TAR,TSH>4.5 mIU/L)和低于范围(TBR,TSH<0.4 mIU/L)与年度平均血压及就诊间血压变异性的关系。线性混合效应模型显示,TAR或TBR增加100%均与平均收缩压和舒张压升高及舒张压变异性小幅增加相关,提示不充分LT4治疗可能通过血压途径影响心血管疾病风险。
要点
- LT4治疗TAR增加100%与年均收缩压升高1.8 mmHg、舒张压升高1.0 mmHg相关。
- LT4治疗TBR增加100%与年均收缩压升高2.7 mmHg、舒张压升高1.3 mmHg相关。
- TAR和TBR增加100%均与就诊间舒张压变异性小幅升高相关。
核心结论
- 不充分的LT4治疗与平均血压及血压变异性升高相关,可能是LT4治疗不充分与心血管疾病之间的潜在中介。
研究设计与样本
- 基于2203例接受LT4治疗的成人患者的纵向数据,采用线性混合效应模型分析个体内年度平均血压和血压变异性的变化。
- 模型调整了社会人口学特征、基线合并症、体重、LT4剂量、时间和研究入组年份。
主要发现
- TAR增加100%与年均收缩压升高1.8 mmHg(P = .011)和舒张压升高1.0 mmHg(P = .024)显著相关。
- TBR增加100%与年均收缩压升高2.7 mmHg(P = .004)和舒张压升高1.3 mmHg(P = .034)显著相关。
- TAR和TBR增加100%分别与年度就诊间舒张压血压变异性升高0.67 mmHg(P = .009)和0.85 mmHg(P = .020)相关。
- TAR和TBR相关的血压差异在后续年份中减弱。
关键数值与推荐
- TAR定义为TSH水平>4.5 mIU/L的时间百分比,TBR定义为TSH<0.4 mIU/L的时间百分比。
- 敏感性分析采用宽范围内边界(TSH 0.1-10 mIU/L)并按基线高血压分层。
临床怎么用
- 临床中应关注LT4治疗患者的TSH目标范围达成情况,避免TAR和TBR,以可能有助于控制血压和血压变异性。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Thyroid hormone homeostasis is critical to the metabolic function of cardiovascular tissues. The degree to which the suboptimal treatment of hypothyroidism with levothyroxine (LT4) impacts blood pressure (BP) and blood pressure variability (BPV) is not known. OBJECTIVES: Determine the relationship between LT4 time above range (TAR) (TSH level >4.5 mIU/L), time below range (TBR) (TSH <0.4 mIU/L), and changes in annual mean systolic (SBP) and diastolic blood pressure (DBP) and visit-to-visit BPV. METHODS: Using longitudinal data from 2203 adult patients treated with LT4, we modeled within-individual changes in annual mean BP and BPV as a function of TAR and TBR (% time). Linear mixed-effect modeling was utilized to allow for differences in observation time between patients. Models were adjusted for sociodemographics, baseline comorbidities, weight, LT4 dose, time, and year of study enrollment. Sensitivity analyses were conducted with wide in-range boundaries (TSH 0.1-10 mIU/L) and stratification by hypertension at baseline. RESULTS: In the primary modeling, a 100% increase in TAR was associated with significant increases in annual mean SBP and DBP (+1.8 mmHg, P = .011; +1.0 mmHg, P = .024, respectively). Similarly, a 100% increase in TBR was associated with increases in annual mean SBP and DBP (+2.7 mmHg, P = .004; +1.3 mmHg, P = .034, respectively). However, the expected differences in BP with TAR and TBR diminished in subsequent years. One hundred percent TAR and TBR were associated with small increases in annual visit-to-visit diastolic BPV (+0.67 mmHg, P = .009; +0.85 mmHg, P = .020, respectively). CONCLUSION: Suboptimal LT4 treatment was associated with increases in mean BP and BPV, representing potential mediators in the pathway between suboptimal LT4 treatment and cardiovascular disease.
引用
- Ettleson MD, Thomas N, Wan W, et al. Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. J Clin Endocrinol Metab. 2026. PMID: 41403148. doi:10.1210/clinem/dgaf675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。